Lab marker
ALT
Alanine aminotransferase · SGPT
The most informative liver enzyme, sensitive to hepatocellular injury, often the first marker to move in MASLD.
What it measures
An intracellular enzyme released into circulation when hepatocytes are injured. More liver-specific than AST. Reported in U/L. Modern guidelines argue the historical 'normal' upper limit was too generous because it was derived from populations that included subclinical liver disease.
Reference context
2 guideline sources
Lab reference ranges typically extend to 40–55 U/L (men) and 30–35 U/L (women), but Prati 2002 and subsequent work demonstrated these were derived from cohorts including undiagnosed MASLD and hepatitis C. Modern healthy thresholds are lower. A 'normal lab' ALT in a person with metabolic syndrome can still mean meaningful liver fat.
Population context: consult guideline targets below
Mechanism
Why moving this marker matters
Hepatocyte injury, from metabolic-associated steatotic liver disease (MASLD, previously NAFLD), alcohol, viral hepatitis, medication injury, releases ALT into circulation. In adults without infectious or pharmacological cause, persistently elevated ALT increasingly reflects MASLD prevalence, which now affects ~30% of adults globally.
Guideline targets
What major guidelines recommend
Prati 2002 (updated healthy ranges)
Men ≤30 U/L; women ≤19 U/L (revised down from historical 40–55 U/L)
AASLD 2017 (action threshold)
Persistently elevated above lab ULN → workup. Even high-normal values should prompt context review when metabolic risk factors are present.
How to measure
The test, where to get it, when to repeat
Method
Standard liver panel as part of routine bloods. Fasting not strictly required but reduces meal-related variability.
Where
Standard GP panel everywhere.
Typical cost
Bundled with liver function tests; €5–15 standalone.
Fasting
Not required
When to test
AASLD 2017 (Kwo)
Evaluate persistently elevated ALT regardless of magnitude; investigate metabolic, alcohol, viral, and drug causes.
EASL 2024 (MASLD)
Screen adults with metabolic risk factors (obesity, T2D, dyslipidaemia) for steatotic liver disease.
Where to test
Independent labs offering this test
Healicus refers you to independent laboratories. You order from the lab; they take the sample, run it, and return your result on their own platform. Healicus never sees your value.
Randox Health
UK · EU · INTLClinic-based premium panels — wider biomarker breadth than home-test brands.
Visit Randox Health
Synlab
DE · EU · INTLEurope-wide medical lab network — referrals via partner GPs and direct-to-consumer programmes where offered.
Visit Synlab
Medichecks
UKUKAS-accredited home blood-test panels with GP-equivalent biomarker coverage.
Visit Medichecks
Thriva
UKApp-first subscription home testing, capillary draw, clinician-reviewed reports.
Visit Thriva
Healicus is not the provider. Your contract for the service is with whoever you choose. Links labelled Sponsored are paid affiliate relationships; unlabelled links are editorial reference only. See our disclosure for the full policy.
Context
Reading the numbers
Lab reference ranges typically extend to 40–55 U/L (men) and 30–35 U/L (women), but Prati 2002 and subsequent work demonstrated these were derived from cohorts including undiagnosed MASLD and hepatitis C. Modern healthy thresholds are lower. A 'normal lab' ALT in a person with metabolic syndrome can still mean meaningful liver fat.
Caveats
Acute hepatitis can elevate ALT 10–100× ULN. Mild persistent elevation in an asymptomatic adult is most commonly MASLD or excess alcohol intake. ALT may be normal in advanced cirrhosis as functioning hepatocytes are depleted; normal ALT does not exclude liver disease in someone with risk factors.
Practices
What's been shown to influence this marker
In a small 6-week crossover trial in 12 adults with fatty liver (Ryan 2013), a Mediterranean diet reduced liver fat on MR spectroscopy more than a low-fat, high-carbohydrate diet, without weight loss; ALT was not the main outcome.
HabitMediterranean dietary pattern
Olive oil, fish, nuts, legumes, plants. Two randomised trials found fewer major cardiovascular events than a low-fat diet.
Why
The Mediterranean pattern, heavy on plants, olive oil, fish, nuts, legumes; moderate fish and dairy; light on red meat, has randomised-trial evidence for fewer major cardiovascular events than a low-fat diet in adults at high cardiovascular risk. PREDIMED, the largest trial (republished after protocol deviations), showed ~30% fewer major cardiovascular events vs. low-fat control. Trial evidence for cognition is thin.
Slot in your day
How to do it
How
Olive oil as the primary fat. Plants at every meal. Fish 2–3× per week. Nuts daily (small handful). Red meat once a week or less. Alcohol is not needed for the pattern; low-volume drinking has not been shown to be protective.
Sticking with it
Stock the kitchen for one week's pattern. Decisions live in the shopping list, not at mealtime.
Markers this may influence
Evidence
Estruch 2018 N Engl J Med RCT (n=7,447, adults at high cardiovascular risk, republished after protocol deviations): a Mediterranean diet with olive oil or nuts had fewer major cardiovascular events than a control diet advising less fat (hazard ratios 0.69 and 0.72). Delgado-Lista 2022 Lancet RCT (n=1,002, coronary heart disease) found a similar direction versus a low-fat diet, mainly in men. Trial evidence for cognition is thin.
GRADE certainty: Moderate — rated by Healicus using the GRADE method (RCT evidence; downgraded for protocol deviations/no blinding in the main trials and for indirectness of dietary-pattern comparisons)
- Estruch et al., NEJM 2018 (PREDIMED)
- Estruch R et al., Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts, N Engl J Med 2018
- Delgado-Lista J et al., Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial, Lancet 2022
- Rees K et al., Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst Rev 2019
- Dinu M et al., Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials, Eur J Clin Nutr 2018
- Sofi F et al., Adherence to Mediterranean diet and health status: meta-analysis, BMJ 2008
- Psaltopoulou T et al., Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis, Ann Neurol 2013
- Valls-Pedret C et al., Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial, JAMA Intern Med 2015
- Petersson SD, Philippou E, Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence, Adv Nutr 2016
- NICE guideline (2020): Acute Coronary Syndromes Guideline (NG185) — Secondary Prevention Visual Summary
- USPSTF guideline (2020): Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions
CautionHabitLimit alcohol intake
Meta-analysis of 107 cohort studies: drinking 45 g or more of alcohol a day was linked to higher all-cause mortality, while low-volume drinking showed no significant difference.
Why
A 2023 JAMA Network Open meta-analysis of 107 cohort studies (n=4,838,825) found higher all-cause mortality in people drinking 45 g or more of alcohol per day than in lifetime nondrinkers, with women at higher risk. Low-volume drinking showed no significant mortality difference once biases were corrected, so light drinking is not shown to be protective. The US Preventive Services Task Force advises screening and brief counselling for adults who drink above recommended limits.
How to do it
How
Track intake honestly for one week. If above threshold, set a weekly cap rather than a daily one (avoids the 'I'll catch up' trap). Several alcohol-free days per week is the simplest pattern. Sleep quality typically improves within 1-2 weeks of reduced intake.
Ideal for
Anyone currently drinking heavily or above recommended limits.
Markers this may influence
Evidence
Zhao 2023 JAMA Netw Open meta-analysis of 107 cohort studies (n=4,838,825): drinkers of 45 g or more of alcohol per day had higher all-cause mortality than lifetime nondrinkers (RR 1.19 and 1.35), while low-volume drinking showed no significant difference. The US Preventive Services Task Force (2018) recommends screening adults and offering brief counselling to those drinking above recommended limits.
GRADE certainty: Low — rated by Healicus using the GRADE method
- GBD 2016 Alcohol Collaborators, Lancet 2018, global burden of alcohol use in 195 countries; minimum-risk consumption is zero
- Zhao J et al., Association Between Daily Alcohol Intake and Risk of All-Cause Mortality: A Systematic Review and Meta-analyses, JAMA Netw Open 2023
- Ronksley PE et al., Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis, BMJ 2011
- USPSTF guideline (2018): Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018)
HabitReduce ultra-processed food
Higher ultra-processed food intake is associated with higher mortality in observational studies; whether cutting it lowers risk is untested.
Why
Foods classified as ultra-processed (NOVA group 4), packaged snacks, sweetened drinks, reformulated meats, ready meals, are associated with higher cardiovascular and all-cause mortality, type 2 diabetes and depression in observational studies. These show association, not that cutting them lowers risk. Proposed mechanisms include altered satiety signalling, additive effects, and displacement of whole foods.
Slot in your day
How to do it
How
Aim for the bulk of the diet to be foods you'd recognise in a kitchen 100 years ago. Convenience foods are fine occasionally; the issue is when they become the default.
Sticking with it
Don't fight cravings in front of the cupboard, fight them at the supermarket.
Markers this may influence
Evidence
Lane 2024 BMJ umbrella review of 45 meta-analyses (n=9,888,373): higher ultra-processed food intake was associated with greater cardiovascular mortality (risk ratio 1.50, very low GRADE certainty) and type 2 diabetes, with highly suggestive links to all-cause mortality and depression. Taneri 2022 and Pagliai 2021 meta-analyses found similar associations. All data were observational, so causation is unproven.
GRADE certainty: Low — rated by Healicus using the GRADE method
- Lane MM et al., Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses, BMJ 2024
- Taneri PE et al., Association Between Ultra-Processed Food Intake and All-Cause Mortality: A Systematic Review and Meta-Analysis, Am J Epidemiol 2022
- Pagliai G et al., Consumption of ultra-processed foods and health status: a systematic review and meta-analysis, Br J Nutr 2021
HabitZone 2 cardio
Conversational-pace cardio, 150+ minutes per week, in line with WHO's moderate-intensity guideline.
Why
Zone 2 is the intensity at which you can still hold a conversation but a song would be a stretch, roughly 60–70% of max heart rate. This exact intensity has not been tested; WHO strongly recommends 150–300 minutes a week of moderate-intensity aerobic activity for adults, and cohort studies link that kind of activity to lower all-cause mortality. Sustained Zone 2 work is proposed to increase mitochondrial density and improve fat oxidation.
Slot in your day
How to do it
How
Brisk walk, easy bike, slow jog. 30 minutes × 5 days, or 45–60 min × 3 days. The 'talk test' is the simplest gauge.
Ideal for
Anyone over 30; especially valuable as the foundation before adding higher-intensity work.
Sticking with it
Schedule it like a meeting. The session you 'fit in if there's time' is the session that doesn't happen.
Markers this may influence
Evidence
WHO's 2020 physical activity guidelines strongly recommend 150-300 minutes a week of moderate-intensity aerobic activity for adults, on moderate-certainty evidence of lower all-cause and cardiovascular mortality. Kelly 2014 Int J Behav Nutr Phys Act meta-analysis of cohort studies: about 11 MET-hours a week of walking or cycling was associated with 11% and 10% lower all-cause mortality. The specific 'zone 2' intensity was not tested.
GRADE certainty: Moderate — reported by WHO 2020 guidelines (moderate certainty for aerobic activity of 150-300 min/week)
See also
Related markers
Take to your physician
Worth discussing
- Whether your value reflects metabolic-associated steatotic liver disease, excess alcohol, medication effect, or something else.
- If persistently elevated, whether FIB-4 score, FibroScan, or imaging (ultrasound, MRI-PDFF) is indicated.
- If MASLD is confirmed, the targeted lifestyle intervention and follow-up cadence.
Sources
Cited literature
- [1]Kwo et al., ACG Clinical Guideline: Evaluation of abnormal liver chemistries (AASLD-endorsed)(2017)
- [2]Prati et al., Updated definitions of healthy ranges for serum alanine aminotransferase levels (Ann Intern Med)(2002)
- [3]EASL-EASD-EASO Clinical Practice Guidelines on the management of MASLD(2024)
- [4]Ryan et al., The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease (J Hepatol)(2013)
Last reviewed October 2026
Keep reading